Breaking News
We're Better Than We Think We Are
A Report from Middle America
Mike Benz reminds MAGA who the REAL enemy is. And it's our fault…
Zionist Billionaires Openly Acknowledge Manipulating the US Government
Top Tech News
The day of the tactical laser weapon arrives
'ELITE': The Palantir App ICE Uses to Find Neighborhoods to Raid
Solar Just Took a Huge Leap Forward!- CallSun 215 Anti Shade Panel
XAI Grok 4.20 and OpenAI GPT 5.2 Are Solving Significant Previously Unsolved Math Proofs
Watch: World's fastest drone hits 408 mph to reclaim speed record
Ukrainian robot soldier holds off Russian forces by itself in six-week battle
NASA announces strongest evidence yet for ancient life on Mars
Caltech has successfully demonstrated wireless energy transfer...
The TZLA Plasma Files: The Secret Health Sovereignty Tech That Uncle Trump And The CIA Tried To Bury
Nano Nuclear Enters The Asian Market
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.